Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04122443 · ClinicalTrials.gov registry record · Phase 4

Acetaminophen (APAP) +/- Oxycodone

A Phase 4 study of Musculoskeletal Pain, sponsored by Montefiore Medical Center.

Completed
Registry status
Phase 4
Development phase
393
Enrollment target
1
Study location

NCT04122443 is a Phase 4 study of Musculoskeletal Pain that has completed, run by Montefiore Medical Center. The registered enrollment target is 393 participants, above the 145-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (171% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04122443, a Phase 4 study of Musculoskeletal Pain, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
393 participants
Enrollment target
1
Study location

Study Summary

This is an emergency department based randomized study of oxycodone/ acetaminophen versus acetaminophen alone for patients with acute musculoskeletal pain refractory to ibuprofen

Conditions Studied

Musculoskeletal Pain

Interventions

  • DRUG Acetaminophen
  • DRUG Oxycodone

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 393 participants
Start Date 2019-12-01
Est. Completion 2022-07-31
Phase Phase 4

Sponsor

Montefiore Medical Center

345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04122443

The ClinicalTrials.gov registry entry for NCT04122443 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 393 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 145-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (171% higher). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Musculoskeletal Pain appearing as the primary indexed condition, and to 2 interventions - of which Acetaminophen is the first listed.

NCT04122443 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04122443 about?

NCT04122443 is a clinical study titled "Acetaminophen (APAP) +/- Oxycodone". This is an emergency department based randomized study of oxycodone/ acetaminophen versus acetaminophen alone for patients with acute musculoskeletal pain refractory to ibuprofen

What is the current status of trial NCT04122443?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 393 participants. The study started on 2019-12-01. Estimated completion is 2022-07-31.

What conditions does trial NCT04122443 study?

This clinical trial studies the following conditions: Musculoskeletal Pain.

What interventions are being tested in trial NCT04122443?

The interventions under investigation include: Acetaminophen (DRUG), Oxycodone (DRUG).

Who is sponsoring clinical trial NCT04122443?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04122443 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Musculoskeletal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Musculoskeletal Pain

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.